Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a ...

NetTargets employs an AI system that combines multi-omics data with neural network modelling for drug discovery.

Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...

Panelists discuss how combination trials like VIALE-A and VIALE-C have demonstrated venetoclax’s survival benefits when added ...

A combination of two cancer drugs significantly boosts lifespan in mice, according to a new study that may lead to better strategies for longevity. The drugs rapamycin and trametinib given together as ...

A new study from Moffitt Cancer Center brings fresh hope to patients battling advanced melanoma who aren’t helped by today’s best treatments. Researchers have found a powerful combination of three ...